Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Denmark
/
Healthcare
/
Embla Medical hf
EMBL
EMBLA
Embla Medical hf
Rising Regulatory And US Tariff Pressures Will Depress Market Prospects
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 3 Analysts
Published
24 Aug 25
Updated
24 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
DKK 28.00
15.7% overvalued
intrinsic discount
24 Aug
DKK 32.40
1Y
7.6%
7D
2.5%
Loading
1Y
7.6%
7D
2.5%
Author's Valuation
DKK 28.0
15.7% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
DKK 28.0
15.7% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
1b
2014
2017
2020
2023
2025
2026
2028
Revenue US$1.1b
Earnings US$108.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.01%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.22%
Calculation
US$108.94m
Earnings '28
x
21.04x
PE Ratio '28
=
US$2.29b
Market Cap '28
US$2.29b
Market Cap '28
/
423.62m
No. shares '28
=
US$5.41
Share Price '28
US$5.41
Share Price '28
Discounted to 2025 @ 7.22% p.a.
=
US$4.39
Fair Value '25
US$4.39
Fair Value '25
Converted to DKK @ 6.3692 USD/DKK Exchange Rate
=
DKK 27.96
Fair Value '25
